FAQs about Serogroup B Meningococcal Disease

Who is at risk of getting serogroup B meningococcal disease?

Anyone can get meningococcal disease and it can be deadly. In fact, 10-15% of all meningococcal disease cases result in death and 1 in 5 cases result in permanent disabilities.

However, some people are at higher risk than others including infants under 1 year old; teens and young adults 16-23 years old; microbiologists who routinely work with isolates of N. meningitides; those with certain medical conditions that affect the immune system; and people in an outbreak setting.

The CDC recommends routine serogroup B meningococcal vaccination (MenB) for those ages 10 and up who are at high risk of contracting the disease and during meningococcal B outbreaks. Vaccination is also available for everyone ages 10 to 23 years old. Ask your child’s healthcare provider about the MenB vaccine, and whether your child should get it. You can also locate vaccine providers who carry serogroup B meningococcal vaccines by using the HealthMap Vaccine Finder.

How many people get serogroup B meningococcal disease?

According to CDC, there are 800 to 1,500 cases of meningococcal disease each year, and approximately one-third of those cases are serogroup B. That means there are 266 to 500 cases of serogroup B meningococcal disease each year.

Serogroup B meningococcal disease outbreaks have recently occurred at several U.S. colleges. Read about how vaccination safely and effectively controlled serogroup B outbreaks on two college campuses here.

Learn more about serogroup B meningococcal disease and the vaccines that help protect against it.

View the Vaccine Information Statement (VIS) for MenB Vaccines.

VIew the VIS for MenB Vaccines in Spanish.